Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79,963,455
-
Total 13F shares
-
11,369,339
-
Share change
-
-863,729
-
Total reported value
-
$19,098,682
-
Put/Call ratio
-
3.1%
-
Price per share
-
$1.68
-
Number of holders
-
57
-
Value change
-
-$446,189
-
Number of buys
-
25
-
Number of sells
-
24
Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q4 2022
As of 31 Dec 2022,
Niagen Bioscience, Inc. - Common Stock (NAGE) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,369,339 shares.
The largest 10 holders included
Tieton Capital Management, LLC, VANGUARD GROUP INC, ICONIQ Capital, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, D. E. Shaw & Co., Inc., and CITADEL ADVISORS LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.